Table 3 Details of the disease occurrence in enrolled patients with gastrointestinal symptoms of long COVID-19 at the 3-month follow-up
Characteristic | After negative | In 1st month | In 1st–2nd month |
|---|---|---|---|
Male, n (%) | 17(63) | 9(56.3) | 1(50) |
Female, n (%) | 10(37) | 7(43.7) | 1(50) |
Age, year (min–max) | 46.2(23–68) | 35.6(27–53) | 35(24,46) |
Hypertension, n (%) | 7(25.9) | 2(12.5) | 1(50) |
Diabetes mellitus, n (%) | 5(18.5) | 0(0) | 0 |
Hyperlipidemia, n (%) | 6(22.2) | 1(6.3) | 0 |
Duration of hospitalization (days) | 12.6(8–17) | 8.2(5–13) | 9(7,11) |
Symptoms at admission, n (%) Fever | 21(77.8) | 9(56.3) | 1(50) |
Gastrointestinal symptoms, n (%) | |||
 Diarrhea | 6(22.2) | 0 | 0 |
 Taste disorder | 18(66.7) | 8(50) | 0 |
Respiratory symptoms, n (%) | |||
 Cough | 10 (37) | 5(31.3) | 2(100) |
 Rhinorrhea (runny nose) | 18(66.6) | 5(31.3) | 0 |
Gastrointestinal symptom of Long COVID, n (%) | |||
 Decreased appetite | 24 (88.9) | 5(31.3) | 1(50) |
 Diarrhea | 9(33.3) | 7(43.8) | 1(50) |
 Xerostomia | 4 (14.8) | 4(25) | 0 |
 Taste disorder | 5(18.5) | 0 | 0 |
 Emaciation | 3(11.1) | 2(12.5) | 0 |
 Abdominal pain | 1(3.7) | 1(6.25) | 1(50) |